{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:07:43Z","timestamp":1794665263767,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2022J011009"],"award-info":[{"award-number":["2022J011009"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2021J01385"],"award-info":[{"award-number":["2021J01385"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2021J01366"],"award-info":[{"award-number":["2021J01366"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2022J01407"],"award-info":[{"award-number":["2022J01407"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171186"],"award-info":[{"award-number":["82171186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2023Y9282"],"award-info":[{"award-number":["2023Y9282"]}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2023Y9309"],"award-info":[{"award-number":["2023Y9309"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15998-3","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T17:07:10Z","timestamp":1755191230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic implications of the high sensitivity C-reactive protein to albumin ratio for major cardiovascular adverse events in patients undergoing noncardiac surgery"],"prefix":"10.1038","volume":"15","author":[{"given":"Yingjie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jundan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"5","key":"15998_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/clinchem\/hvad005","volume":"69","author":"FK Borges","year":"2023","unstructured":"Borges, F. K. et al. High-sensitivity troponin I predicts, Ajor cardiovascular events after non-Cardiac surgery: A vascular events in non-cardiac surgery patients cohort evaluation (VISION) substudy. Clin. Chem. 69 (5), 492\u2013499 (2023).","journal-title":"Clin. Chem."},{"issue":"39","key":"15998_CR2","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","volume":"43","author":"S Halvorsen","year":"2022","unstructured":"Halvorsen, S. et al. 2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur. Heart J. 43 (39), 3826\u20133924 (2022).","journal-title":"Eur. Heart J."},{"issue":"20","key":"15998_CR3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2008.03.005","volume":"51","author":"D Poldermans","year":"2008","unstructured":"Poldermans, D., Hoeks, S. E. & Feringa, H. H. Pre-operative risk assessment and risk reduction before surgery. J. Am. Coll. Cardiol. 51 (20), 1913\u20131924 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"15998_CR4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/eurheartj\/eht014","volume":"34","author":"M Karakas","year":"2013","unstructured":"Karakas, M. & Koenig, W. Improved peri-operative risk stratification in non-cardiac surgery: going beyond established clinical scores. Eur. Heart J. 34 (11), 796\u2013798 (2013).","journal-title":"Eur. Heart J."},{"issue":"10","key":"15998_CR5","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1515\/cclm-2022-0481","volume":"60","author":"A Clerico","year":"2022","unstructured":"Clerico, A. et al. Evaluation of the cardiovascular risk in patients undergoing major non-cardiac surgery: role of cardiac-specific biomarkers. Clin. Chem. Lab. Med. 60 (10), 1525\u20131542 (2022).","journal-title":"Clin. Chem. Lab. Med."},{"issue":"21","key":"15998_CR6","doi-asserted-by":"publisher","first-page":"13540","DOI":"10.3390\/ijms232113540","volume":"23","author":"JL Romero-Cabrera","year":"2022","unstructured":"Romero-Cabrera, J. L., Ankeny, J., Fern\u00e1ndez-Montero, A., Kales, S. N. & Smith, D. L. A systematic review and meta-Analysis of advanced biomarkers for predicting incident cardiovascular disease among asymptomatic middle-aged adults. Int. J. Mol. Sci. 23 (21), 13540 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"15998_CR7","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1093\/eurheartj\/ehm234","volume":"28","author":"A Struthers","year":"2007","unstructured":"Struthers, A. & Lang, C. The potential to improve primary prevention in the future by using BNP\/N-BNP as an indicator of silent \u2018pancardiac\u2019 target organ damage: BNP\/N-BNP could become for the heart what microalbuminuria is for the kidney. Eur. Heart J. 28 (14), 1678\u20131682 (2007).","journal-title":"Eur. Heart J."},{"key":"15998_CR8","doi-asserted-by":"publisher","first-page":"106157","DOI":"10.1016\/j.phrs.2022.106157","volume":"178","author":"A Hafiane","year":"2022","unstructured":"Hafiane, A. & Daskalopoulou, S. S. Targeting the residual cardiovascular risk by specific anti-inflammatory interventions as a therapeutic strategy in atherosclerosis. Pharmacol. Res. 178, 106157 (2022).","journal-title":"Pharmacol. Res."},{"issue":"12","key":"15998_CR9","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N. Engl. J. Med. 377 (12), 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"15998_CR10","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif, J. C. et al. Efficacy and safety of low-dose Colchicine after myocardial infarction. N. Engl. J. Med. 381 (26), 2497\u20132505 (2019).","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"15998_CR11","doi-asserted-by":"publisher","first-page":"e208098","DOI":"10.1212\/WNL.0000000000208098","volume":"102","author":"S Chaturvedi","year":"2024","unstructured":"Chaturvedi, S. & De Marchis, G. M. Inflammatory biomarkers and stroke subtype. Neurology 102 (2), e208098 (2024).","journal-title":"Neurology"},{"issue":"20","key":"15998_CR12","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","volume":"138","author":"C Yao","year":"2018","unstructured":"Yao, C. et al. Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation. Circulation 138 (20), 2227\u20132242 (2018).","journal-title":"Circulation"},{"issue":"8","key":"15998_CR13","doi-asserted-by":"publisher","first-page":"e019168","DOI":"10.1161\/JAHA.120.019168","volume":"10","author":"AP Benz","year":"2021","unstructured":"Benz, A. P. et al. Biomarkers of inflammation and risk of hospitalization for heart failure in patients with atrial fibrillation. J. Am. Heart Association. 10 (8), e019168 (2021).","journal-title":"J. Am. Heart Association"},{"issue":"10","key":"15998_CR14","doi-asserted-by":"publisher","first-page":"e005610","DOI":"10.1161\/JAHA.117.005610","volume":"6","author":"A Wang","year":"2017","unstructured":"Wang, A. et al. Cumulative exposure to high-sensitivity C-reactive protein predicts the risk of cardiovascular disease. J. Am. Heart Association. 6 (10), e005610 (2017).","journal-title":"J. Am. Heart Association"},{"key":"15998_CR15","doi-asserted-by":"publisher","first-page":"108165","DOI":"10.1016\/j.pharmthera.2022.108165","volume":"235","author":"J Zeller","year":"2022","unstructured":"Zeller, J. et al. Transitional changes in the structure of C-reactive protein create highly pro-inflammatory molecules: therapeutic implications for cardiovascular diseases. Pharmacol. Ther. 235, 108165 (2022).","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"15998_CR16","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1373\/clinchem.2011.169839","volume":"57","author":"S Devaraj","year":"2011","unstructured":"Devaraj, S., Kumaresan, P. R. & Jialal, I. C-reactive protein induces release of both endothelial microparticles and Circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction. Clin. Chem. 57 (12), 1757\u20131761 (2011).","journal-title":"Clin. Chem."},{"issue":"10118","key":"15998_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","volume":"391","author":"PM Ridker","year":"2018","unstructured":"Ridker, P. M. et al. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet (London England). 391 (10118), 319\u2013328 (2018).","journal-title":"Lancet (London England)"},{"issue":"13","key":"15998_CR18","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","volume":"582","author":"M Roche","year":"2008","unstructured":"Roche, M., Rondeau, P., Singh, N. R., Tarnus, E. & Bourdon, E. The antioxidant properties of serum albumin. FEBS Lett. 582 (13), 1783\u20131787 (2008).","journal-title":"FEBS Lett."},{"issue":"3","key":"15998_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/07853890.2018.1441537","volume":"50","author":"SK Kunutsor","year":"2018","unstructured":"Kunutsor, S. K., Seidu, S., Katechia, D. T. & Laukkanen, J. A. Inverse association between serum albumin and future risk of venous thromboembolism: interrelationship with high sensitivity C-reactive protein. Ann. Med. 50 (3), 240\u2013248 (2018).","journal-title":"Ann. Med."},{"issue":"5","key":"15998_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/oxfordjournals.aje.a010232","volume":"151","author":"JJ Nelson","year":"2000","unstructured":"Nelson, J. J. et al. Serum albumin level as a predictor of incident coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Am. J. Epidemiol. 151 (5), 468\u2013477 (2000).","journal-title":"Am. J. Epidemiol."},{"issue":"6","key":"15998_CR21","doi-asserted-by":"publisher","first-page":"e12928","DOI":"10.1111\/eci.12928","volume":"48","author":"Y Karaba\u011f","year":"2018","unstructured":"Karaba\u011f, Y. et al. Usefulness of the C-reactive protein\/albumin ratio for predicting no-reflow in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Eur. J. Clin. Invest. 48 (6), e12928 (2018).","journal-title":"Eur. J. Clin. Invest."},{"issue":"17","key":"15998_CR22","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.3390\/jcm11175067","volume":"11","author":"JH Jang","year":"2022","unstructured":"Jang, J. H., Hong, S. & Ryu, J. A. Prognostic value of C-reactive protein and albumin in neurocritically ill patients with acute stroke. J. Clin. Med. 11 (17), 5067 (2022).","journal-title":"J. Clin. Med."},{"issue":"1","key":"15998_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2012.02.021","volume":"222","author":"DM Gualandro","year":"2012","unstructured":"Gualandro, D. M. et al. Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous. Atherosclerosis 222 (1), 191\u2013195 (2012).","journal-title":"Atherosclerosis"},{"issue":"5","key":"15998_CR24","first-page":"550","volume":"10","author":"L Sazgary","year":"2020","unstructured":"Sazgary, L. et al. Incidence of major adverse cardiac events following non-cardiac surgery. Eur. Heart J. Acute Cardiovasc. Care. 10 (5), 550\u2013558 (2020).","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"15998_CR25","doi-asserted-by":"crossref","unstructured":"Mathew, G., Agha, R. & for the STROCSS Group. STROCSS,. : Strengthening the Reporting of cohort, cross-sectional and case-control studies in Surgery. International Journal of Surgery 2021;96: 6165. (2021).","DOI":"10.1016\/j.ijsu.2021.106185"},{"issue":"1","key":"15998_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/ALN.0000000000002703","volume":"131","author":"B Saugel","year":"2019","unstructured":"Saugel, B. et al. Automated ambulatory blood pressure measurements and intraoperative hypotension in patients having noncardiac surgery with general anesthesia: A prospective observational study. Anesthesiology 131 (1), 74\u201383 (2019).","journal-title":"Anesthesiology"},{"issue":"4","key":"15998_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/EJA.0000000000000735","volume":"35","author":"L Hallqvist","year":"2018","unstructured":"Hallqvist, L., Granath, F., Huldt, E. & Bell, M. Intraoperative hypotension is associated with acute kidney injury in noncardiac surgery: an observational study. Eur. J. Anaesthesiol. 35 (4), 273\u2013279 (2018).","journal-title":"Eur. J. Anaesthesiol."},{"issue":"1","key":"15998_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.7326\/0003-4819-152-1-201001050-00007","volume":"152","author":"MK Ford","year":"2010","unstructured":"Ford, M. K., Beattie, W. S. & Wijeysundera, D. N. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Ann. Intern. Med. 152 (1), 26\u201335 (2010).","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"15998_CR29","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.mayocp.2021.11.022","volume":"97","author":"H Seoudy","year":"2022","unstructured":"Seoudy, H. et al. C-Reactive protein to albumin ratio in patients undergoing transcatheter aortic valve replacement. Mayo Clin. Proc. 97 (5), 931\u2013940 (2022).","journal-title":"Mayo Clin. Proc."},{"key":"15998_CR30","doi-asserted-by":"publisher","first-page":"4711018","DOI":"10.1155\/2022\/4711018","volume":"2022","author":"P Kang","year":"2022","unstructured":"Kang, P., Kang, W., Li, Y. & Li, T. C-Reactive protein-to-albumin ratio as an early biomarker to identify sepsis in neonates with pneumonia. Mediat. Inflamm. 2022, 4711018 (2022).","journal-title":"Mediat. Inflamm."},{"issue":"10","key":"15998_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/jcm7100333","volume":"7","author":"JE Park","year":"2018","unstructured":"Park, J. E. et al. The C-reactive potein\/albumin ratio as a predictor of mortality in critically ill patients. J. Clin. Med. 7 (10), 333 (2018).","journal-title":"J. Clin. Med."},{"key":"15998_CR32","doi-asserted-by":"publisher","first-page":"637650","DOI":"10.3389\/fcell.2021.637650","volume":"9","author":"J Zhou","year":"2021","unstructured":"Zhou, J. et al. Prognostic value of C-reactive protein, Glasgow prognostic score, and C-reactive protein-to-albumin ratio in colorectal cancer. Front. Cell. Dev. Biology. 9, 637650 (2021).","journal-title":"Front. Cell. Dev. Biology"},{"issue":"11","key":"15998_CR33","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/jech-2023-220760","volume":"77","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. High levels of high-sensitivity C reactive protein to albumin ratio can increase the risk of cardiovascular disease. J. Epidemiol. Commun. Health. 77 (11), 721\u2013727 (2023).","journal-title":"J. Epidemiol. Commun. Health"},{"issue":"1","key":"15998_CR34","doi-asserted-by":"publisher","first-page":"11583","DOI":"10.1038\/s41598-019-48189-y","volume":"9","author":"W Wang","year":"2019","unstructured":"Wang, W., Ren, D., Wang, C. S., Li, T. & Yao, H. C. High sensitivity C-reactive protein to prealbumin ratio measurement as a marker of the prognosis in acute coronary syndrome. Sci. Rep. 9 (1), 11583 (2019).","journal-title":"Sci. Rep."},{"key":"15998_CR35","doi-asserted-by":"publisher","first-page":"731261","DOI":"10.3389\/fcvm.2021.731261","volume":"8","author":"L Cheng","year":"2021","unstructured":"Cheng, L. et al. The usefulness of C-reactive protein to albumin ratio in the prediction of adverse cardiovascular events in coronary chronic total occlusion undergoing percutaneous coronary intervention. Front. Cardiovasc. Med. 8, 731261 (2021).","journal-title":"Front. Cardiovasc. Med."},{"issue":"9","key":"15998_CR36","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1177\/00033197221110715","volume":"73","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. The association between high-sensitivity C-reactive protein\/albumin ratio and cardiovascular prognosis in patients undergoing percutaneous coronary intervention. Angiology 73 (9), 818\u2013826 (2022).","journal-title":"Angiology"},{"issue":"5","key":"15998_CR37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","volume":"62","author":"O Yousuf","year":"2013","unstructured":"Yousuf, O. et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J. Am. Coll. Cardiol. 62 (5), 397\u2013408 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"15998_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12944-023-01836-w","volume":"22","author":"SEC Bafei","year":"2023","unstructured":"Bafei, S. E. C. et al. Interactive effect of increased high sensitive C-reactive protein and dyslipidemia on cardiovascular diseases: a 12-year prospective cohort study. Lipids Health Dis. 22 (1), 95 (2023).","journal-title":"Lipids Health Dis."},{"issue":"1","key":"15998_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/aje\/kwv144","volume":"183","author":"GM Lin","year":"2016","unstructured":"Lin, G. M. et al. Low-density lipoprotein cholesterol concentrations and association of high-sensitivity C-reactive protein concentrations with incident coronary heart disease in the multi-ethnic study of atherosclerosis. Am. J. Epidemiol. 183 (1), 46\u201352 (2016).","journal-title":"Am. J. Epidemiol."},{"issue":"40","key":"15998_CR40","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.2174\/1381612820666140622201452","volume":"20","author":"K Tziomalos","year":"2014","unstructured":"Tziomalos, K., Karagiannis, A. & Athyros, V. G. Effects of lipid-lowering agents on inflammation, haemostasis and blood pressure. Curr. Pharm. Design. 20 (40), 6306\u20136313 (2014).","journal-title":"Curr. Pharm. Design"},{"issue":"10384","key":"15998_CR41","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","volume":"401","author":"PM Ridker","year":"2023","unstructured":"Ridker, P. M. et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving Statin therapy: a collaborative analysis of three randomised trials. Lancet (London England). 401 (10384), 1293\u20131301 (2023).","journal-title":"Lancet (London England)"},{"issue":"4","key":"15998_CR42","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","volume":"3","author":"SS Khan","year":"2018","unstructured":"Khan, S. S. et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 3 (4), 280\u2013287 (2018).","journal-title":"JAMA Cardiol."},{"issue":"1","key":"15998_CR43","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s12889-021-10606-1","volume":"21","author":"B Iyen","year":"2021","unstructured":"Iyen, B. et al. Long-term body mass index changes in overweight and obese adults and the risk of heart failure, cardiovascular disease and mortality: a cohort study of over 260,000 adults in the UK. BMC Public. Health. 21 (1), 576 (2021).","journal-title":"BMC Public. Health"},{"issue":"10","key":"15998_CR44","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1161\/01.CIR.100.10.1043","volume":"100","author":"TH Lee","year":"1999","unstructured":"Lee, T. H. et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 (10), 1043\u20131049 (1999).","journal-title":"Circulation"},{"issue":"12","key":"15998_CR45","first-page":"Cd013139","volume":"12","author":"LM Vernooij","year":"2021","unstructured":"Vernooij, L. M. et al. The comparative and added prognostic value of biomarkers to the revised cardiac risk index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery. Cochrane Database Syst. Rev. 12 (12), Cd013139 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"15998_CR46","first-page":"1215","volume":"37","author":"PS Roshanov","year":"2021","unstructured":"Roshanov, P. S. et al. Predicting myocardial injury and other cardiac complications after elective noncardiac surgery with the revised cardiac risk index: the VISION study. Can. J. Cardiol. 37 (8), 1215\u20131224 (2021).","journal-title":"Can. J. Cardiol."},{"key":"15998_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s44254-025-00096-4","volume":"3","author":"H Boughaleb","year":"2025","unstructured":"Boughaleb, H. et al. Exploring the association of erythrocytic NO-ferroheme, a surrogate marker of endothelial function with perioperative cardiovascular events in low\/intermediate risk patients undergoing elective non-cardiac surgery. Anesthesiology Perioperative Sci. 3, 16 (2025).","journal-title":"Anesthesiology Perioperative Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15998-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15998-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15998-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T04:51:54Z","timestamp":1757393514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15998-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15998"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15998-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"11 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical review and approval were waived for this study because the data were fully deidentified and no interventions were performed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"29876"}}